Chongqing Genrix Biopharmaceutical Co (SHSE:688443) Cash Flow for Lease Financing : ¥0.00 Mil (TTM As of Mar. 2025)

View and export this data going back to 2023. Start your Free Trial

What is Chongqing Genrix Biopharmaceutical Co Cash Flow for Lease Financing?

Chongqing Genrix Biopharmaceutical Co's Cash Flow for Lease Financing for the three months ended in Mar. 2025 was ¥0.00 Mil. Chongqing Genrix Biopharmaceutical Co's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.00 Mil.

Compared with last quarter (¥0.00 Mil in Dec. 2024 ), Chongqing Genrix Biopharmaceutical Co's Cash Flow for Lease Financing remained the same in Mar. 2025 (¥0.00 Mil).

Chongqing Genrix Biopharmaceutical Co Cash Flow for Lease Financing Historical Data

The historical data trend for Chongqing Genrix Biopharmaceutical Co's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chongqing Genrix Biopharmaceutical Co Cash Flow for Lease Financing Chart

Chongqing Genrix Biopharmaceutical Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Cash Flow for Lease Financing

Get a 7-Day Free Trial

Chongqing Genrix Biopharmaceutical Co Quarterly Data
	Dec19	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Cash Flow for Lease Financing	Get a 7-Day Free Trial												-	-	-	-	-

Chongqing Genrix Biopharmaceutical Co Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.

Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.00 Mil.

Chongqing Genrix Biopharmaceutical Co Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Chongqing Genrix Biopharmaceutical Co's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Chongqing Genrix Biopharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chongqing Genrix Biopharmaceutical Co Ltd (SHSE:688443) » Definitions » Cash Flow for Lease Financing

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 699, Maliu Avenue, Area A, Building 2, International Bio City, Banan, Chongqing, CHN, 401338

Website

http://www.genrixbio.com

Chongqing Genrix Biopharmaceutical Co Ltd is engaged in the research & development, production and sales of antibody drugs. The company has a total of more than ten products under research covering three major therapeutic areas. The progress of core products is leading, and some product pipelines are as follows; autoimmune disease, infectious disease, and tumor. Its product Xeligekimab injection (Xeligekimab) is a recombinant fully human anti-IL-17A monoclonal antibody independently developed by the company, which has been accepted by the National Medical Products Administration (NMPA) for new drug marketing applications.

Executives

Jiang Ren Sheng

Director

Chongqing Genrix Biopharmaceutical Co Headlines

No Headlines